Perimeter Medical Imaging AI, Inc.

Equities

PINK

CA71385D1078

Advanced Medical Equipment & Technology

Delayed Toronto S.E. Other stock markets 03:16:44 2024-04-29 pm EDT			5-day change	1st Jan Change
0.55 ^CAD	-21.43%		-27.63%	-54.92%

Apr. 22	Perimeter Medical Imaging AI, Inc.(TSXV:PINK) dropped from S&P/TSX Venture Composite Index	CI
Apr. 16	Transcript : Perimeter Medical Imaging AI, Inc. - Special Call

Perimeter Medical Imaging AI initiates new clinical trial site in Seattle, WA

October 31, 2023 at 03:24 pm EDT

(via NewsDirect)

Adrian Mendes, the CEO of Perimeter Medical Imaging, joined Steve Darling from Proactive with news that the company has initiated an additional clinical trial site at the University of Washington in the Fred Hutch Cancer Center.

Perimeter's clinical trial is a multi-center, randomized, two-arm pivotal study that evaluates the investigational Perimeter B-Series Optical Coherence Tomography (OCT) technology. This technology is combined with Perimeter's proprietary ImgAssist AI software and is used during breast conservation surgeries.

The core of this innovative approach is the use of ultra-high-resolution, real-time, advanced imaging tools to examine excised tissues at the cellular level, providing crucial insights to surgeons.

Mendes emphasized the significance of this additional clinical trial site, as it plays a vital role in gathering valuable data generated during the study. This data will be instrumental in supporting the commercialization of Perimeter's B-Series technology.

The company's ultimate goal is to transform cancer surgery by providing advanced technology that not only improves patient outcomes but also helps reduce healthcare costs.

Contact Details

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com

Latest news about Perimeter Medical Imaging AI, Inc.

Perimeter Medical Imaging AI, Inc.(TSXV:PINK) dropped from S&P/TSX Venture Composite Index	Apr. 21	CI
Transcript : Perimeter Medical Imaging AI, Inc. - Special Call	Apr. 15
Perimeter Medical Imaging AI to Participate at Annual Meeting of the American Society of Breast Surgeons	Apr. 05	MT
Perimeter Medical Imaging AI, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Transcript : Perimeter Medical Imaging AI, Inc., Q4 2023 Earnings Call, Mar 28, 2024	Mar. 28
Perimeter Medical Imaging AI Provides Corporate Update On Grant Funding Opportunities	Mar. 20	MT
Perimeter Medical Imaging AI, Inc. Announces Results from New Study 1 Published in the Annals of Surgical Oncology	Feb. 20	CI
Perimeter Medical Imaging AI Provides Update	Feb. 07	MT
Perimeter Medical Imaging AI, Inc. Announces Expanded Commercial Presence Within National Healthcare Provider System with Follow-On Placement of Perimeter S-Series Oct At Additional Hospital Site	Feb. 07	CI
Perimeter Medical Imaging AI Announces Further Commercial Expansion in North Texas	Dec. 14	MT
Transcript : Perimeter Medical Imaging AI, Inc. - Shareholder/Analyst Call	Dec. 06
Transcript : Perimeter Medical Imaging AI, Inc. - Special Call	Nov. 30
Perimeter Medical Imaging AI, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Transcript : Perimeter Medical Imaging AI, Inc., Q3 2023 Earnings Call, Nov 14, 2023	Nov. 14
Perimeter Medical Imaging AI Initiating New Clinical Trial Site At University Of Washington/Fred Hutch Cancer Center	23-10-31	MT
Perimeter Medical Imaging AI, Inc. Announces Initiation of Additional Clinical Trial Site at University of Washington / Fred Hutch Cancer Center Located in Seattle, WA	23-10-31	CI
Transcript : Perimeter Medical Imaging AI, Inc. - Special Call	23-10-25
Perimeter Medical Imaging AI, Inc.(TSXV:PINK) added to S&P/TSX Venture Composite Index	23-10-22	CI
Perimeter Medical Imaging AI Announces Patient Randomization Underway at Clinical Trial Site at Mayo Clinic in Florida	23-10-11	MT
Perimeter Medical Imaging Ai, Inc. Announces Patient Randomization Underway At Clinical Trial Site At Mayo Clinic in Florida	23-10-11	CI
Perimeter Medical Imaging Shortlisted to Advance to Next Stage of Grant Funding Program in the US	23-10-05	MT
Perimeter Medical Imaging AI, Inc. Announces Alignment with FDA on Key Elements of Ongoing Clinical Trial	23-09-07	CI
Transcript : Perimeter Medical Imaging AI, Inc., Q2 2023 Earnings Call, Aug 29, 2023	23-08-29
Perimeter Medical Imaging AI, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-28	CI
Perimeter Medical Imaging AI Reports First Commercial Placement of Perimeter S-Series OCT in the State of Georgia	23-08-17	MT

Chart Perimeter Medical Imaging AI, Inc.

Duration

Period

Chart Perimeter Medical Imaging AI, Inc.

More charts

Company Profile

Perimeter Medical Imaging AI, Inc. is a medical technology company driven to transform cancer surgery with resolution, real-time, imaging tools to address high unmet medical needs. It develops and commercializes in-procedural medical imaging tools. The Companyâs Perimeter Optical Coherence Tomography (OCT) system, which provides cross-sectional, real-time margin visualization of tissue microstructures during surgical procedures. The Perimeter S-Series OCT is designed to provide surgeons with the clinical support they need in the OR. The OCT medical imaging system includes an intraoperative device for automated scanning of a tissue specimen that provides a rapid subsurface map of up to a 10 cm by 10 cm surface area; a specimen-handling consumable designed to hold and maintain orientation of the specimen, and an image library and training set. Its machine learning tools and artificial intelligence technology, called ImgAssist AI, through clinical development under its ATLAS AI project.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-27 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Perimeter Medical Imaging AI, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.7 CAD

Average target price

4.375 CAD

Spread / Average Target

+525.00%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Imaging Systems

	1st Jan change	Capi.
PERIMETER MEDICAL IMAGING AI, INC.	-54.92%	33.26M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-3.22%	14.6B
IRAY TECHNOLOGY COMPANY LIMITED	-36.36%	2.71B
SONOSCAPE MEDICAL CORP.	-12.35%	2.44B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-12.00%	1.51B
CORETAG, INC.	-.--%	1.12B
NANO-X IMAGING LTD.	+40.42%	518M
GUERBET	+89.74%	502M
DETECTION TECHNOLOGY OYJ	+12.77%	239M
VIEWORKS CO., LTD.	+1.30%	183M

Medical Imaging Systems